A consultation is required to determine medical eligibility and ensure peptide therapy is appropriate given the health history, goals, and lab results
Dueweke JJ, Awan TM, Mendias CL
Stasinopoulos, A controlled clinical pilot trial to study the effectiveness of ice as a supplement to the exercise programme for the management of lateral elbow tendinopathy, British journal of sports medicine 40, no
The peptide is not approved by regulatory agencies such as the FDA or EMA for therapeutic use, and is currently available only for research purposes
after reconstitution, refrigerate at 28 C (35.646.4 F)
J Biol Chem 2002;277:252038